EANS-Adhoc: Publication pursuant to Sections 4 and 5 of the Publication Ordinance 2002 INTERCELL AG, ISIN: AT0000612601
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.
20.07.2010
Since 2002, the shareholders meeting of Intercell AG has issued stock options on a regular basis to members of the management board, the supervisory board and employees. According to section 98 para 3 and section 159 para 2 lit 3 of the Austrian stock corporation act, the management board has published a report on the option grant. In connection with the exercise of stock options during the last exercise window in June/July 2010 the Company intends to use own shares held as treasury stock, in addition to new shares issued from conditional capital.´
Therefore, the Management Board of Intercell AG has resolved on July 16, 2010 in accordance with the Supervisory Board, to transfer own shares held as treasury stock, which have been acquired according to the resolutions of the Shareholders Meetings held on May 24, 2002, on July 14, 2003 and on June 1, 2004 to members of the management board, the supervisory board and employees of Intercell AG in connection with the exercise of stock options.
Based on the above mentioned resolutions of the Shareholders Meetings, in which the authorizations to re-purchase own shares were approved according to Section 65 para 1 lit 4 of the Austrian stock corporations act, Intercell AG herewith informs about the upcoming transfer of up to 150,000 own shares of common stock with no par value, corresponding to up to 0.31 percent of the share capital of Intercell AG, to members of the management board, the supervisory board and employees of Intercell AG between July 23, 2010 and August 31, 2010. The transfer shall be conducted over-the-counter at a sales price equivalent to the exercise price of the stock options ranging from EUR 3.99 to EUR 11.43 per share. The transfer shall not affect the admission of shares of Intercell AG at the Vienna Stock exchange.
Until now, the following numbers of stock options have been granted to members of the Supervisory Board, members of the Management Board, executive employees and other employees (excluding options that have been cancelled):
Beneficiaries Number of options
Members of the Supervisory Board Michel Gréco 51,250 Ernst Afting 51,250 David Ebsworth 45,000 James R. Sulat 47,500 Hans Wigzell 45,000 Mustapha Leavenworth Bakali 50,000
Members of the Management Board Gerd Zettlmeissl 475,000 Thomas Lingelbach 350,000 Reinhard Kandera 187,000
Executive employees 1,002,400 Other employees 246,850 Employees of subsidiaries 818,687
Total 3,369,937
According to Section 7 para 2 in connection with Section 5 para 4 of the Publication Ordenance 2002 Intercell AG informs, that the disclosure obligation according to Section 7 of the Publication Ordenance 2002 (completion of the transfer) shall be effected via the internet. The information according to Section 7 of the Publication Ordenance 2002 shall be posted on the webpage of Intercell AG under www.intercell.com.
INTERCELL AG
end of announcement euro adhoc
Further inquiry note:
Intercell AG
Gerald Strohmaier
Global Head Corporate Finance & Investor Relations
Tel. +43 1 20620-1229
investors@intercell.com
Branche: Biotechnology
ISIN: AT0000612601
WKN: A0D8HW
Index: ATX Prime, ATX
Börsen: Wien / official market